Posted by Michael Wonder on 08 May 2017
Involving patients in discussions on benefits and risks of medicines
8 May 2017 - EMA publishes report on CHMP pilot project.
The EMA has published a final report on the experience gained during its pilot project to involve patients directly in the assessment of the benefits and risks of medicines in its Committee for Medicinal Products for Human Use.
The report concludes that patients should continue to be invited to oral explanations when their input could be valuable to the assessment of a medicine. This could be the case, for example, when the Committee is considering whether to recommend the authorisation of a new medicine or the maintenance, suspension or revocation of an existing authorisation, or a restriction of indication of an authorised medicine.
